221 related articles for article (PubMed ID: 20204276)
1. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
[TBL] [Abstract][Full Text] [Related]
2. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
3. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
[TBL] [Abstract][Full Text] [Related]
4. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
[TBL] [Abstract][Full Text] [Related]
5. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
[TBL] [Abstract][Full Text] [Related]
6. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
7. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
9. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
[TBL] [Abstract][Full Text] [Related]
10. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
[TBL] [Abstract][Full Text] [Related]
11. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
[TBL] [Abstract][Full Text] [Related]
12. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
[TBL] [Abstract][Full Text] [Related]
13. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression.
Kageshita T; Hirai S; Ono T; Hicklin DJ; Ferrone S
Am J Pathol; 1999 Mar; 154(3):745-54. PubMed ID: 10079252
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
16. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S
Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358
[TBL] [Abstract][Full Text] [Related]
18. Identification of domain boundaries within the N-termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin-mediated increase in peptide loading of MHC class I.
Procko E; Raghuraman G; Wiley DC; Raghavan M; Gaudet R
Immunol Cell Biol; 2005 Oct; 83(5):475-82. PubMed ID: 16174096
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing.
Hicklin DJ; Kageshita T; Ferrone S
Tissue Antigens; 1996 Jul; 48(1):38-46. PubMed ID: 8864173
[TBL] [Abstract][Full Text] [Related]
20. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]